Dr. Lei Qian, MD, PhDInnoventbio における Chief R&D Officer, General Biomedicineスピーカー
プロフィール
Dr. Lei Qian serves as Chief R&D Officer at Innoventbio. A board-certified endocrinologist with prior clinical practice at a teaching hospital, Dr. Qian brings 15 years of expertise in clinical development and medical affairs, specializing in metabolic diseases, immunology, and ophthalmology. He has successfully led the development of over 12 therapeutic assets, including four that achieved regulatory approval in China.
アジェンダセッション
Clinical Development of Mazdutide, the First Dual GCG/GLP-1 Receptor Agonist Approval in China, for Chronic Weight Management
, 4:30pmセッションを見る